Your browser doesn't support javascript.
loading
Genetic variants associated with acamprosate treatment response in alcohol use disorder patients: A multiple omics study.
Ho, Ming-Fen; Zhang, Cheng; Wei, Lixuan; Zhang, Lingxin; Moon, Irene; Geske, Jennifer R; Skime, Michelle K; Choi, Doo-Sup; Biernacka, Joanna M; Oesterle, Tyler S; Frye, Mark A; Seppala, Marvin D; Karpyak, Victor M; Li, Hu; Weinshilboum, Richard M.
Affiliation
  • Ho MF; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Zhang C; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Wei L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Zhang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Moon I; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Geske JR; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
  • Skime MK; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
  • Choi DS; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Biernacka JM; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
  • Oesterle TS; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
  • Frye MA; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
  • Seppala MD; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
  • Karpyak VM; Hazelden Betty Ford Foundation, Center City, Minnesota, USA.
  • Li H; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
  • Weinshilboum RM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
Br J Pharmacol ; 179(13): 3330-3345, 2022 07.
Article de En | MEDLINE | ID: mdl-35016259
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Substances à effet antabuse / Alcoolisme Type d'étude: Risk_factors_studies Limites: Humans Langue: En Journal: Br J Pharmacol Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Substances à effet antabuse / Alcoolisme Type d'étude: Risk_factors_studies Limites: Humans Langue: En Journal: Br J Pharmacol Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni